Clinical Chemistry AACC Online Job Center
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 54: 93-100, 2008. First published November 16, 2007; 10.1373/clinchem.2007.093450
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
clinchem.2007.093450v1
54/1/93    most recent
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pérez-Cerdá, C.
Right arrow Articles by Ugarte, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pérez-Cerdá, C.
Right arrow Articles by Ugarte, M.
Related Collections
Right arrow Molecular Diagnostics and Genetics
(Clinical Chemistry. 2008;54:93-100.)
© 2008 American Association for Clinical Chemistry, Inc.

Molecular Diagnostics and Genetics

Screening Using Serum Percentage of Carbohydrate-Deficient Transferrin for Congenital Disorders of Glycosylation in Children with Suspected Metabolic Disease

Celia Pérez-Cerdá1, Dulce Quelhas2, Ana I. Vega1, Jesús Ecay1, Laura Vilarinho2 and Magdalena Ugarte1,a

1 Centro de Diagnóstico de Enfermedades Moleculares, Dpto. de Biología Molecular CBM-SO, Facultad de Ciencias, Universidad Autónoma de Madrid, 28049 Madrid, Spain, CIBER de Enfermedades Raras; 2 Medical Genetic Institute, Clinical Biology Department, Porto, Portugal.

aAddress correspondence to this author at: Centro de Diagnóstico de Enfermedades Moleculares, Dpto de Biología Molecular CBM-SO, Facultad de Ciencias, Universidad Autónoma de Madrid, 28049 Madrid, Spain. Fax 34-91-7347797; e-mail mugarte{at}cbm.uam.es.

Background: Diagnoses of congenital disorders of glycosylation (CDG) are based on clinical suspicion and analysis of transferrin (Tf) isoforms. Here we present our experience of CDG screening in children with a suspected metabolic disease by determination of serum percentage of carbohydrate-deficient transferrin (%CDT) in tandem with isoelectric focusing (IEF) analysis of Tf and {alpha}1-antitrypsin ({alpha}1-AT).

Methods: We performed approximately 8000 serum %CDT determinations using %CDT turbidimetric immunoassay (TIA). In selected samples, IEF analysis of Tf and {alpha}1-AT was carried out on an agarose gel (pH 4–8) using an electrophoresis unit. The isoforms were detected by Western blotting and visualized by color development. We performed neuraminidase digestion of serum to detect polymorphic variants of Tf.

Results: We established a cutoff value for serum %CDT of 2.5% in our pediatric population. Sixty-five patients showed consistently high values of serum %CDT. In accordance with Tf and {alpha}1-AT IEF profiles, enzyme assays, and mutation analysis, we made the following diagnoses: 23 CDG-Ia, 1 CDG-Ib, and 1 conserved oligomeric Golgi 1 (COG-1) deficiency. In addition, we identified 13 CDG-Ix non Ia, non-Ib; 3 CDG-Ix; and 9 CDG-IIx cases, albeit requiring further characterization; 9 patients with a secondary cause of hypoglycosylation and 6 with a polymorphic Tf variant were also detected.

Conclusion: The combined use of CDT immunoassay with IEF of Tf and {alpha}1-AT is a useful 1st-line screening tool for identifying CDG patients with an N-glycosylation defect. Additional molecular investigations must of course be carried out to determine the specific genetic disease.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by the American Association for Clinical Chemistry.